Global and United States Osteoporosis Therapeutics Market Report & Forecast 2022-2028

Osteoporosis is a silent epidemic and as per the WHO declarations, it is a priority health issue. Osteoporosis is a disruption of bone architecture and decrease in bone mass, leading to a number of complications including increased chances of bone fractures and reduced bone strength. The most common sites of osteoporosis are the spine, hip and forearm, although it also affects other body parts.
Market Analysis and Insights: Global and United States Osteoporosis Therapeutics Market
This report focuses on global and United States Osteoporosis Therapeutics market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Osteoporosis Therapeutics market size is estimated to be worth US$ 10660 million in 2022 and is forecast to a readjusted size of US$ 12110 million by 2028 with a CAGR of 2.2% during the review period. Fully considering the economic change by this health crisis, by Type, Bisphosphonates accounting for % of the Osteoporosis Therapeutics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Distribution Channel, Hospital Pharmacies was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
The osteoporosis therapeutic market has become very competitive due to the high number of new drug approvals, although the majority of them are incremental innovations of existing therapies. Competition is fierce, particularly among bisphosphonates and selective estrogen receptor modulators (SERMs), which are mostly used as first-line therapy and dominate the treatment market for osteoporosis patients.
Global Osteoporosis Therapeutics Scope and Market Size
Osteoporosis Therapeutics market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Osteoporosis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Osteoporosis Therapeutics market size by players, by Type and by Distribution Channel, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
Bisphosphonates
Hormones
Strontium Ranelate
Raloxifene
Denosumab
Others
Segment by Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Warner Chilcott
Merck & Co.
Roche
Novartis
Ono
Astellas Pharma
Procter & Gamble
Sumitomo Pharmaceuticals
Servier
Eli Lilly
Pfizer
Amgen
Chugai